Molecular Formula | C15H18Cl2N2O2S |
Molar Mass | 361.29 |
Melting Point | 196-200 |
Solubility | ethanol: 10mg/mL |
Appearance | powder |
Color | white |
Storage Condition | 2-8°C |
Use | ML-9 is a selective potent inhibitor of Akt kinase, which inhibits the activities of myosin light chain kinase (MLCK) and matrix interacting molecule 1 (STIM1). ML-9 inhibit MLCK,PKA and PKC activities with Ki values of 4, 32 and 54 μM respectively. ML-9 induce autophagy (autophagy) by stimulating the formation of autophagosomes and inhibiting their degradation. |
WGK Germany | 3 |
Hazard Note | Harmful |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.768 ml | 13.839 ml | 27.679 ml |
5 mM | 0.554 ml | 2.768 ml | 5.536 ml |
10 mM | 0.277 ml | 1.384 ml | 2.768 ml |
5 mM | 0.055 ml | 0.277 ml | 0.554 ml |
biological activity | ML-9 HCl (ML-9 hydrochloride) is a potent and selective Akt kinase, myosin light chain (MLCK) and stromal interaction molecule 1 (STIM1). ML-9 HCl is also a potent inhibitor of Ca2 -permeable channels. ML-9 HCl is a lysosomal agent that targets autophagy and cell death. |
Target | Value |
Cell Line: | Neonatal rat ventricularmyocytes(NRVM)cells Neonatal rat ventricularmyocytes(NRVM)cells |
Concentration: | 0, 10, 50 and 100 μM 50 μM |
Incubation Time: | 0, 1, 4, 8 and 24 hours 1, 4 and 8 hours |
Result: | Decreased cell viability at 50-100 μM concentration. Induced cardiomyocyte death throughnecrosisand apoptosis. |